Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection - Wikidata - awgldk - TriplyDB

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection

http://www.wikidata.org/entity/Q34646648

about

Novel Strategies in the Prevention and Treatment of Urinary Tract Infections Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links Iron and zinc exploitation during bacterial pathogenesis Urinary Tract Infection: Pathogenesis and Outlook.Human Urinary Composition Controls Antibacterial Activity of Siderocalin.Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection.Macrophagic control of the response to uropathogenic E. coli infection by regulation of iron retention in an IL-6-dependent manner.Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine.Diverging roles of bacterial siderophores during infection.Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.Siderophore-mediated iron acquisition and modulation of host-bacterial interactions.Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.Metal homeostasis in infectious disease: recent advances in bacterial metallophores and the human metal-withholding response.Urinary tract infection: recent insight into the evolutionary arms race between uropathogenic Escherichia coli and our immune system.Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.Copper Is a Host Effector Mobilized to Urine during Urinary Tract Infection To Impair Bacterial Colonization.Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease.Neutrophil gelatinase-associated lipocalin: utility in urologic conditions.Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?

P2860

Q26772924-BD7622DE-A5E4-443D-A656-3BF81ADACC3B Q26782663-D54D16CF-F4C1-415A-947E-6ABF78C9F2AC Q28082191-C83F0884-3C38-41EF-9EED-FB17A59A7024 Q30244953-70AC5DDD-1C17-4184-9A9C-9CC2BA0FB6C9 Q35783053-E5958A41-93B1-44BA-A65F-2F6A69635818 Q35866812-BB69B318-8825-4581-8AD6-D210474CFB3B Q36251958-180B4C1C-A106-413B-A28F-B730BC428528 Q37467621-938D00F7-9045-48B3-88F6-1F641293C802 Q37551280-D1266D4D-7AAB-4415-8A19-428D975288CB Q38368718-3C49DB0D-96E5-437A-A31B-3411B6045DF3 Q38543398-32AA0F26-5AE0-4BEE-BC7F-F981D534D907 Q38990713-C1B9313C-498E-43C2-B995-D6A0A1331C29 Q39003164-81371FC5-A2C6-4DB5-AB5C-CE933756AACA Q39043309-EEF115E9-3ABD-4735-9D3D-BDF5313A3153 Q40279563-2D8E82E0-BC8F-4D5A-9470-E3262DDC5AB1 Q40283099-EB11B6DB-2D42-429C-A113-4A741C4BA58A Q40306598-839619E2-73C9-4D6B-927C-5205B0B3E4C7 Q40392431-8B16B884-036C-4A97-9115-1FDC33A25C54 Q40536632-8AB4A5B5-A876-4AAE-B942-92979C5738CF Q44522587-8A8D7D3A-ED94-4F5B-AFAE-393593D06646 Q47258530-FFA5364C-1292-42AC-8BEF-1472AC31F218

P2860

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection

http://www.wikidata.org/entity/Q34646648

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Lipocalin 2 imparts selective ...... n with urinary tract infection

@ast

Lipocalin 2 imparts selective ...... n with urinary tract infection

@en

Lipocalin 2 imparts selective ...... n with urinary tract infection

@nl

type

label

Lipocalin 2 imparts selective ...... n with urinary tract infection

@ast

Lipocalin 2 imparts selective ...... n with urinary tract infection

@en

Lipocalin 2 imparts selective ...... n with urinary tract infection

@nl

prefLabel

Lipocalin 2 imparts selective ...... n with urinary tract infection

@ast

Lipocalin 2 imparts selective ...... n with urinary tract infection

@en

Lipocalin 2 imparts selective ...... n with urinary tract infection

@nl

P1433

Q34646648-E5FB834C-9E20-4D8F-A828-7C72362DA071

P1476

Q34646648-D46DB2F8-C634-4197-8595-4B411E6C3037

P2093

Q34646648-46A892CC-8F7F-4E89-8D5C-863952BAC30A

Q34646648-4B808E23-5E9F-420F-A46E-2635894FF0D5

Q34646648-7F55A318-92BB-417F-9FEB-D6791AC6693D

Q34646648-8FF1B640-686C-429E-904A-FFCDF896C4C3

Q34646648-BB017E34-9C02-4711-837D-8CE21F0A3AC2

Q34646648-CB0EE18E-7C37-4754-A1ED-B1B1C5C56DDB

Q34646648-CD5DC0C9-3748-496A-80AB-878F58300444

Q34646648-EA53E818-DC7D-4332-88B5-D93D5E77E20D

Q34646648-F92A9326-4871-4538-AD95-7A105D7219A5

P2860

Q34646648-00D8AD18-E481-440C-8C55-61D221F2B8A5

Q34646648-03AA38AD-86EB-4B72-8827-CEB57EC44FBD

Q34646648-19A612B2-DF3C-4C41-B3BD-40CC6781CBE7

Q34646648-225B880D-6F28-4EC9-8362-AB83972C5C28

Q34646648-2E130953-EBBB-424E-A467-B5CDC000B3F3

Q34646648-37FB3BD2-CAEB-493D-88C4-9AAF37907852

Q34646648-4909637F-5482-4764-B362-5D83AD77F611

Q34646648-4D81E92C-2EB0-4014-AEB5-3C9B99F9A533

Q34646648-54EFB7AC-CB88-4556-A57D-B55ED60280E3

Q34646648-63D6C09B-4152-40EC-A7DD-F752D9A70166

P304

Q34646648-494A5737-F0C6-4BFF-B25E-7CD79C0C111C

P31

Q34646648-07A5F8E6-612E-4BFA-AC8C-D5066A164B32

P356

Q34646648-A6853879-E9C8-4F20-9D3B-9C5A40873D5D

P407

Q34646648-B57BBA1B-636F-4027-9B60-21089CFDE978

P433

Q34646648-2ABE33F2-9903-49C1-B837-15F025459348

P478

Q34646648-15E69D7E-4DDF-4415-BF2E-0E6C3A279C39

P50

Q34646648-30B52891-15C0-4516-B26C-B8BC75FC6610

Q34646648-3B53D1CE-417F-4901-9896-9F4A38E9C22F

Q34646648-EE14A5FF-338D-4A00-97DB-E800EB4E708A

P577

Q34646648-033C153F-5FA8-4210-84A4-E34B1B08F455

P5875

Q34646648-1518C28F-4BC2-49BE-82BF-D16C5EC841DD

P698

Q34646648-F3F94195-C494-41C4-AEE5-2C982E2C3003

P932

Q34646648-7F1F2CC9-A0C6-49B8-99E3-5351ADAD2595

P356

JIMMUNOL.1401528

P1433

Journal of Immunology

P1476

Lipocalin 2 imparts selective ...... n with urinary tract infection

@en

P2093

Anne Marstad

http://www.w3.org/2001/XMLSchema#string

Jan K Damås

http://www.w3.org/2001/XMLSchema#string

Markus Haug

http://www.w3.org/2001/XMLSchema#string

Pacita L Roberts

http://www.w3.org/2001/XMLSchema#string

Roland K Strong

http://www.w3.org/2001/XMLSchema#string

Stephanie D Himpsl

http://www.w3.org/2001/XMLSchema#string

Thomas M Hooton

http://www.w3.org/2001/XMLSchema#string

Thomas R Hawn

http://www.w3.org/2001/XMLSchema#string

Trude H Flo

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

NGAL-Siderocalin in kidney disease

The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection

Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron

Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse.

Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway.

A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.

Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled.

P304

6081-6089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1401528

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

Ann E. Stapleton

Magnus Steigedal

Harry L T Mobley

P577

2014-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268336411

http://www.w3.org/2001/XMLSchema#string

P698

25398327

http://www.w3.org/2001/XMLSchema#string

P932

4258450

http://www.w3.org/2001/XMLSchema#string